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ABSTRACT
Four distinct eukaryotic initiation factor 2α (eIF2α) kinases phosphorylate eIF2α
at Ser-51 and regulate protein synthesis in response to cellular stress conditions.
This kinase family includes the hemin-regulated inhibitor (HRI); the double-
stranded RNA-dependent kinase (PKR); the GCN2 protein kinase; and the
endoplasmic reticulum-resident kinase (PERK). HRI mediates protein synthesis
inhibition in heme-deficient reticulocyte lysates. Although HRI contains two
putative heme regulatory motifs (HRMs) that are not present in other eIF2α kinases,
the significance of these motifs in heme regulation is not clear. In fact, it had been
characterized two novel eIF2α kinases from Schizosaccharomyces pombe that lacked
any of the HRMs, but were sensitive to heme regulation in vitro. To investigate the
importance of different regions in the regulation of HRI by heme, specific HRI
mutants were generated, and kinase activities and heme responsiveness were
analyzed in vitro. Mutational analysis indicated that the heme regulatory motifs
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were spread around some regions in the HRI catalytic domain, outside of the HRMs.
In accordance with these results, both the autokinase and the eIF2α kinase activities
of three distinct eIF2α kinases, including the human PKR, the mouse GCN2 and the
Drosophila PERK were inhibited in vitro by hemin. Although the known regulatory
mechanisms of these eIF2α kinases are very different, the data reported here
indicate that all known eIF2α kinases are regulated in vitro by hemin. This finding
provides evidence that hemin represents a regulatory mechanism unique to eIF2α
kinases and underscores the role of hemin in the translational regulation of
eukaryotic cells.
Key words: eIF2α kinases.—Translational control.—Heme-regulated kinase.—
Heme regulatory domain.
RESUMEN
La respuesta a hemina in vitro es una característica compartida por todos
los miembros de la familia de las eIF2α quinasas
Las cuatro eIF2α quinasas eucarióticas fosforilan el residuo Ser-51 de la subuni-
dad alfa del factor de iniciación 2 y regulan la síntesis de proteínas en respuesta a
situaciones de estrés celular. Esta familia de proteínas quinasas está formada por el
inhibidor regulado por hemina (HRI); la quinasa dependiente de RNA de doble
cadena (PKR); la proteína quinasa GCN2 y la quinasa residente en el retículo endo-
plásmico (PERK). El HRI inhibe la síntesis de proteínas en lisados de reticulocitos
de conejo deficientes de hemina. Aunque el HRI contiene dos supuestos motivos
reguladores de hemina (HRMs), que no están presentes en las otras eIF2α quinasas,
no está claro aún el papel de estos motivos en la regulación por hemina. De hecho,
se han caracterizado dos nuevas eIF2α quinasas de Schizosaccharomyces pombe que
carecen de dichos HRMs, pero son sensibles a la regulación por hemina in vitro. Un
análisis mutacional indicó que los motivos reguladores de hemina estaban dis-
persos a lo largo del dominio catalítico, fuera de los HRMs. De acuerdo con estos
resultados, las actividades autoquinasa y eIF2α quinasa de tres eIF2α quinasas dis-
tintas, la PKR humana, la GCN2 de ratón y la PERK de Drosophila, se inhibían por
hemina in vitro. Aunque los mecanismos de regulación de todas estas eIF2α quina-
sas son muy diferentes, nuestros resultados indican que todas las eIF2α quinasas se
regulan por hemina in vitro. Este descubrimiento soporta la evidencia de que la
hemina representa un mecanismo de regulación específico de las eIF2α quinasas, y
subraya su papel en la regulación de la traducción de células eucarióticas.
Palabras clave: eIF2α quinasas.—Control de la Traducción.—Quinasa regulada
por hemina.—Dominio regulador de hemina.
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INTRODUCTION
In eukaryotic cells, protein synthesis is mainly regulated at
the level of initiation of mRNA translation. The reversible
phosphorylation of the α-subunit of eukaryotic translation initiation
factor 2 (eIF2α) is a well-characterized mechanism of translational
control in response to a wide variety of cellular stresses, including
nutrient starvation, iron deficiency, heat shock, UV irradiation
and viral infection (1, 2). Four different eIF2α kinases have been
identified that specifically phosphorylate eIF2α on Ser-51. All known
eIF2α kinases share a conserved kinase domain linked to unique
regulatory regions. Thus, HRI is activated both by heme deficiency
and under conditions of heat shock and oxidative stress (3). PKR
is induced by interferon (IFN) and activated by double-stranded
RNA (dsRNA) during viral infection (4). GCN2 (general control
non-derepressible-2) is an eIF2α kinase that is activated by amino
acid or serum deprivation and UV irradiation (5-7). The fourth eIF2α
kinase, PERK, is activated by unfolded proteins in the endoplasmic
reticulum (ER) (8, 9). It has recently cloned and characterized two
novel eIF2α kinases from the fission yeast S. pombe (named SEK1/
Hri1p and SEK2/Hri2p) both of which show higher homology with
mammalian HRI than with other eIF2α kinases (10).
HRI, found most abundantly in erythroid cells, serves to limit
globin protein synthesis when the levels of available heme are
low. However, the presence of HRI mRNA and HRI activity in
non-erythroid tissues and in NIH 3T3 cells raises the possibility
of additional regulatory roles for HRI (11). The eIF2α kinase
GCN2 was originally characterized in Saccharomyces cerevisiae
and GCN2 homologs have been identified in Drosophila melanogaster
(12) and mammals (5), suggesting that GCN2 might be the founding
and also the best conserved member of the eIF2α kinase family (2).
PERK was originally identified in rat pancreatic islet cells (8) and,
recently, PERK homologs have been found in mouse, human,
and Drosophila melanogaster (9, 13). Interestingly, when activated by
their cognate upstream stress signals, the mammalian PERK and
GCN2 repress translation of most mRNAs but selectively increase
translation of ATF4 mRNA, a member of the activating transcription
family (14).
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All distinct eIF2α kinases share extensive homology in the kinase
catalytic domain. Apart from the 12 conserved subdomains found in
most protein kinases, they have additional characteristic features,
including an insert region between subdomains IV and V and a
conserved sequence in subdomain V that distinguishes them from
other serine/threonine kinases (15). Especially notable is the presence
of this conserved motif, essentially LY/HIQME/QY/LC, located N-
terminal to subdomain V in all of the known members (up to 20) of
this kinase family, suggesting that this motif might contain a putative
substrate-specific recognition domain (16).
HRI is regulated by heme, and it seems that heme binds directly
to HRI and blocks kinase activity (17). In fact, it has been shown
that HRI is a hemoprotein with two distinct heme-binding sites
(17, 18). Both of them, the N-terminus and the kinase insertion,
which are unique to HRI, appear to be involved in the heme
regulation of HRI (18). Furthermore, HRI is among six hemoproteins
that have a putative heme regulatory motif (HRM) (19); HRI contains
two of these motifs that are not present in other eIF2α kinases,
although the role of the HRMs in the heme regulation of full-length
HRI remains uncertain. Thus, the heme-binding site responsible for
the reversible heme regulation of HRI must be determined in order
to understand the mechanism of the regulation of HRI by heme.
In this study we have examined the effects of several deletions
and point mutations in specific regions of HRI on its activity by
in vitro assays. We have also tested these mutants of HRI for
responsiveness to heme. Our findings indicate that none of three
unique regions in HRI, the N-terminus, the kinase insertion and
the C-terminus are required for the regulation of HRI by heme.
Furthermore, we have found that both the autokinase and the eIF2α
kinase activities of the other members of the eIF2α kinase family,
such as PKR, GCN2 and PERK, were also sensitive to hemin in vitro.
We conclude that the heme-binding site responsible for the reversible
heme regulation is located within the eIF2α kinase domain and
this conserved motif(s) is characteristic of all known members of the
eIF2α kinase family.
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MATERIAL AND METHODS
HRI Mutagenesis and Plasmid Construction
All HRI expression constructs were generated from pRSETB-
MHRI plasmid, which harbors wild type (wt) mHRI (11). Single
point mutations C409A and C550A were made by using the
QuickChangeTM site-directed mutagenesis kit (Strategene) as
described by the manufacturer, using the mutagenic primers shown
in Table I. HRI Δ8 and HRI Δ8/C550A were generated from pRSETB-
MHRI and pRSETB-MHRI/C550A plasmids, respectively, by
substitution of the cDNA fragment encoding aa 1 to 413 with a PCR
generated fragment encoding aa 1 to 405. The resultant plasmids,
pRSETB-MHRI Δ8 and pRSETB-MHRI Δ8/C550A, encode HRI
proteins lacking the 406 to 413 aa residues alone, or together with
the C550A point mutation. To generate the HRI Δ137/C409A/C550A
mutant, the pRSETB-MHRI C409A/C550A plasmid was cut with
BamHI, yielding three fragments. The fragment corresponding to the
HRI central region (aa 138-501) was subcloned to produce a plasmid
encoding an HRI product that lacks the 1 to 137 aa residues and
contains the C409A and C550A mutations. HRI 138-580/C409A/C550A
was generated by substituting the Gln-581 CAA codon for a stop
codon (UAA) in the pRSETB-MHRI Δ137/C409A/C550A plasmid.
HRI Q4 chimera was obtained as follows: the whole pRSETB-
MHRI plasmid without the region corresponding to the HRI kinase
insert domain (residues 235-389) (11) was amplified by PCR,
introducing restriction sites at both ends. The kinase insert domain
(residues 656-807) of GCN2 (5) was also amplified by PCR
introducing the same restriction sites. Both generated DNA
fragments were ligated to produce a pRSETB-MHRI Q4 vector
encoding an HRI protein with the MGCN2 insert sequence.
Prokaryotic expression of HRI proteins
The pRSETB-MHRI-wt and the pRSETB-MHRI-mutant plasmids
were used to transform a competent BL21 (DE3) pLys S strain of
E. coli. Protein expression and bacterial lysis were done as previously
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described (11). Bacterial lysates were diluted (1/100) in 20 mM Tris-
HCl (pH 7.4) and assayed for their ability to phosphorylate eIF2α as
described below.
TABLE I. Sequences of mutagenic HRI oligonucleotides
Construct Mutagenic primer *
HRI C409A 5’-GTGGACGAAGCTGCTGCTCCCTATGTTATGGC (sense)
5’-GCCATAACATAGGGAGCAGCAGCTTCGTCCAC (antisense)
HRI C550A 5’-CCCTCAGTAAAAGGGCTCCGGTGCAAGCC (sense)
5’-GGCTTGCACCGGAGCCCTTTTACTGAGGG (antisense)
HRI 138-580 5’-CAGAGTGAGCTTTTTTAAACAACTGGAAATG (sense)
5’-CATTTCCAGTTGTTTAAAAAAGCTCACTCTG (antisense)
* Underlined codons correspond to the indicated amino acid mutations and the generated
stop codon. The changed nucleotides are marked in bold.
Cell Culture and Transfection
HEK 293T cells were grown and transfected as previously
described (20). The plasmids used were the pcDNA3.1/Myc-His
vectors (Invitrogen) containing the coding region of mouse GCN2
(pcMGCN2-WT) (5), mouse HRI (pcMHRI-WT) (11), human PKR
(provided by Dr. J. Gil), Drosophila melanogaster PERK (13), or rat
ζPKC (21) in frame with a C-terminal tag encoding the myc epitope
and a polyhistidine metal-binding peptide.
Affinity Purification and in vitro Phosphorylation Assays
Affinity purification of proteins was performed as previously
described (20). The eluted proteins from the metal affinity resin as
well as the E. coli lysates containing the HRI wild type and mutant
proteins were assayed for their ability to phosphorylate eIF2α as
reported previously (12, 22), with modifications as described. In a
total volume of 20 μl, 5 μl of kinase fractions were incubated with
various concentrations of hemin (0-4 μM) for 30 min at 30º C in the
kinase buffer (20 mM Tris-HCl (pH 7.6), 2.5 mM MgCl2, 2.5 mM
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Mg(OAc)2, 0.25 mg/ml BSA, 50 μM ATP) containing purified rabbit
reticulocyte eIF2 (0.5 μg) and 3 μCi of [γ-32P] ATP (3000 Ci/mmol).
When PKR or GCN2 was assayed the reaction mixtures also included
1 μg/ml poly(I)·poly(C) dsRNA or 2.5 μg/ml (0.65 nM) Sindbis virus
RNA, respectively. Phosphorylation of casein (Sigma) by highly
purified casein kinase II (CKII) from rat liver was carried out as
described (22). Briefly, purified CKII (0.01 U/ml) was incubated for
10 min at 30º C with 66 μg/ml casein as substrate and 3 μCi of
[γ-32P] ATP (3000 Ci/mmol) in a final volume of 30 μl containing
20 mM Tris-HCl (pH 7.2), 8 mM MgCl2, 0.5 mM EGTA, 0.5 mM
EDTA, 1 mM dithiothreitol and 50 μM ATP. ζPKC kinase assay was
as for eIF2α kinases, except for the substitution of Mg(OAc)2 by
MgCl2 and eIF2α by 3 μg of myelin basic protein (MBP) as substrate.
Incubations were terminated by the addition of SDS sample buffer
and phosphoproteins were analyzed by both SDS-PAGE (23) on a 10
or 12.5% polyacrylamide gel (28.5:1 (w/w) acrylamide/bisacrylamide)
and autoradiography using Agfa Curix RP2 film and an Amersham-
Pharmacia intensifying screen. The areas corresponding to the
phosphorylated α-subunit of eIF2 were scanned at 633 nm in a
computing 300 A densitometer (Molecular Dynamics, Inc.).
RESULTS
All known HRIs contain two putative heme regulatory motifs
(HRM): ACPYVM and RCPVQA, which are located within the
catalytic domain [(11) and Fig. 1B] and are not present in other
eIF2α kinases. To date, the significance of these motifs in the heme
regulation of HRI is unknown.
To understand the regulation mechanism of HRI by heme, we
designed and constructed a series of mutants (Fig. 1A), including
point mutations of the two invariant cysteine residues in the HRMs
(HRI C409A/C550A) alone or together with either a large N-terminal
deletion (HRI Δ137/C409A/C550A) or deletions that remove both the
N-terminal and the C-terminal domains (HRI 138-580/C409A/C55A).
The HRI Δ8 mutant contains a deletion of amino acids 406-413 that
removes the entire HRM1. The HRI Δ8/C550A mutant also contains
a single point mutation of conserved cysteine in HRM2. In addition,
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FIGURE 1. A, the 619 amino acid wild type HRI sequence is illustrated by a large
box and shown at the top. The black boxes represent the conserved two lobes of
the eIF2α kinase domain, separated by a large insert region (stippled boxes)
between subdomains IV and V. Position of the two heme regulatory motifs (HRM1
and 2) within the catalytic domain is shown. Six generated mutants are shown:
HRI C409A/C550A (in which the conserved cysteines in both HRM1 and HRM2
are mutated to alanine); HRI Δ137/C409A/C550A (previous mutant in which the
first 137 amino acids were deleted); HRI 138-580/C409A/C550A (previous mutant
with the indicated deletion at the C-terminus); HRI Δ8 (an eight-amino acid
deletion in HRM1); HRI Δ8/C550A (mutant containing HRM1 deletion and C550A
substitution); HRI Q4 (in which the insert region of HRI kinase was replaced by
the corresponding insert region from mouse GCN2). The numbers refer to the
amino acid residues. B, the five domains of mouse HRI included the N-terminus
(N); the conserved two lobes of the eIF2α kinase domain separated by a large
insert (amino acids 236-373); and the C-terminus (C) are indicated. The 11
invariant residues and the two HRMs, within the eIF2a kinase domain, that are
absent in other Ser/Thr protein kinases are also indicated.
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we constructed the HRI Q4 mutant, in which the entire kinase insert
together with the N-terminal of HRI kinase subdomain V (11) was
replaced by the corresponding amino acid sequence of mouse GCN2
(5). All the HRI constructs in pRSETB vector (11) were efficiently
expressed in E. coli and the amounts of recombinant proteins, tested
by Western blot, were similar (data not shown).
To assess the kinase activity of the HRI mutants, an in vitro
kinase assay was performed in which bacterial extracts containing
these mutants were tested for phosphorylation of exogenously added
eIF2. Under these conditions, the extent of inhibition of eIF2α kinase
activity of the wild type and HRI mutants by heme was dependent
upon the amount of HRI used.
To determine the role of the HRMs in the heme regulation of
HRI we studied the effect of hemin on the eIF2α kinase activity
of three different HRI mutants, C409A/C550A, Δ8, and Δ8/C550A.
For all of the mutants, eIF2α kinase activity was similar to that of
the wild type HRI. Furthermore, the eIF2α kinase activity of HRI
mutants was also hemin-sensitive (Fig. 2A). Interestingly, the extent
of inhibition of HRI mutants by heme was similar to that of HRI wt
at all hemin concentrations tested (Fig. 2B). The concentration of
hemin required for 50% inhibition of eIF2α kinase activity was about
0.3-0.5 μM for wild type HRI, in good agreement with earlier studies
(3, 18), and 0.3 μM, 0.4 μM and 0.7 μM for C409A/C550A, Δ8 and Δ8/
C550A mutants, respectively. These results strongly suggest that the
entire HRM1 and the cysteine residue in HRM2 have no apparent
effect on the heme-responsiveness of HRI in vitro.
Similarly, to determine the role of both amino and carboxyl ends
in the heme regulation of HRI, the inhibition by heme of the eIF2α
kinase activity of the two indicated HRI deletion mutants, also
containing point mutations into the HRMs (Δ137/C409A/C550A and
138-580/C409A/C550A), were compared. In this case, the eIF2α kinase
activity of mutants was also inhibited by the same concentration
range of hemin (Fig. 2A), although we obtained slightly different
values in the hemin concentration required for their half-maximal
inhibition (Fig. 2B). These results suggest that neither N- nor C-
terminal domains are essential in the heme regulation of HRI.
Finally, the mutant HRI Q4, in which the HRI kinase insert had been
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FIGURE 2. A, samples of recombinant HRI wt, as a control; HRI C409A/C550A;
HRI Δ8; HRI Δ8/C550A; HRI Δ137/C409A/C550A; HRI 138-580-C409A/C550A;
and HRI Q4 proteins were analyzed for their ability to phosphorylate purified
rabbit reticulocyte eIF2, in the presence of increasing concentrations of hemin
as indicated. Position of phosphorylated eIF2α is indicated. B, the phosphorylation
of eIF2α was estimated by quantifying the corresponding band density of the
autoradiograms. The intensity of the eIF2α band at zero concentration of hemin
was defined as 100%. The figure shows a representative experiment of at least
three independent experiments with very similar results.
replaced by the mouse GCN2 corresponding region, showed lower
eIF2α kinase activity (Fig. 2A). Probably due to its low specific
activity, HRI Q4 was more sensitive to inhibition by heme (0.4 μM
for 50% inhibition) than that of wild type HRI (Fig. 2B). This result
suggests that the kinase insert region, which does not show any
significant homology with those of the other eIF2α kinases, may not
be the important region for achieving the heme responsiveness of
HRI. Altogether, our mutational analysis indicates that the heme
regulatory region(s) are spread around the 12 conserved subdomains
characteristic of all eukaryotic Ser/Thr protein kinases.
Because the kinase catalytic region of HRI was responsible for
heme regulation, we tested whether the other eIF2α kinases, besides
mammalian HRI, could be inhibited by hemin in vitro. To this end,
we used purified eIF2α kinases from transfected HEK 293T cells:
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mouse HRI (as positive control), mouse GCN2, human PKR, and
Drosophila PERK. In order to achieve full activity of GCN2 and PKR,
they were assayed in the presence of Sindbis virus RNA (20) and
poly(I)·poly(C), respectively (Fig. 3A). Of great interest was the
finding that both the autokinase and eIF2α kinase activities of the
affinity-purified recombinant eIF2α kinases were inhibited by low
FIGURE 3. A, autokinase and eIF2α kinase activities of distinct eIF2α kinases are
inhibited by hemin. All four eIF2α kinases (mouse HRI and GCN2, human PKR
and Drosophila PERK) were expressed in HEK 293T cells as Myc-His fusion
proteins and purified by affinity chromatography. In vitro phosphorylation assays
were performed in the absence or presence of the indicated increasing
concentrations of hemin, as described under Material and Methods. The positions
of phosphorylated HRI, GCN2, PKR, PERK and eIF2α are indicated. B, eIF2α
phosphorylation was estimated by denstitometric analysis as described for Fig. 2.
C, eIF2α kinase activity of both S. pombe eIF2α kinases, SEK1 and SEK2, is
inhibited by hemin. All three eIF2α kinases (mouse HRI and S. pombe SEK1 and
SEK2) were expressed in E. coli, as previously reported. In vitro phosphorylation
assays were performed in the absence or presence of the indicated concentrations
of hemin. D, eIF2α phosphorylation was estimated and represented as in B.
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concentrations of hemin (Fig. 3A). Moreover, the extent of inhibition
of all of them by heme was similar to that of mouse HRI at all hemin
concentrations tested (Fig. 3B). We therefore conclude that the
kinase activities of different eIF2α kinases are also regulated in vitro
by hemin.
Moreover, the two novel eIF2α kinases from S. pombe (SEK1/
Hri1p and SEK2/Hri2p) were also heme-responsive in vitro (Fig. 3C).
Again, the extent of the inhibition of SEK1 and SEK2 by heme was
similar to that of mouse HRI at all concentrations tested (Fig. 3D).
Altogether, our results indicate that the responsiveness to hemin in
vitro is a common property of all the other eIF2α kinases.
We were interested in ascertaining the possible specificity for the
hemin effect reported here. In order to see if other protein kinases,
in addition to eIF2α kinases, were heme responsive, we tested the
effect of hemin on the protein kinase activity of two other Ser/Thr
protein kinases, CKII and ζPKC. The data presented in Fig. 4
demonstrated that the in vitro phosphorylation of either casein, by
CKII, or MBP, by ζPKC, was not inhibited by the presence of hemin.
We therefore conclude that the eIF2α kinases, but not other serine-
FIGURE 4. A, shown are the results from the in vitro phosphorylation of eIF2α by
recombinant mouse HRI, as a control, of casein by purified casein kinase II, and
of MBP by purified His-tagged ζPKC, in the absence or presence of the indicated
concentrations of hemin. The positions of phosphorylated eIF2α, casein and MBP
are indicated. B, the phosphorylation of eIF2α, casein and MBP was estimated as
described in Figure 2.
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threonine protein kinases, are regulated in vitro by hemin, suggesting
that the putative heme-regulatory motifs are shared by all members
of the eIF2α kinase family.
DISCUSSION
The molecular mechanism(s) by which hemin regulates
mammalian HRI has yet to be determined. Furthermore, the precise
heme-binding domain responsible for rapid regulation of HRI by
heme is not characterized. Some previous reports have suggested
that purified HRI is a homodimer and a hemoprotein with two
distinct heme-binding sites. Binding of heme to an N-terminal
domain (amino acids 1-138) of HRI is stable and autonomous,
whereas binding to a kinase-insertion domain (amino acids 241-406)
is dynamic and may be responsible for the reversible heme regulation
of HRI (18). It should be noted that this reported kinase-insertion
domain contains not only the entire mouse kinase insert sequence
unique to HRI but also includes the kinase subdomain V and the
adjacent amino acids (LHIQMQLC), a highly conserved motif among
eIF2α kinases. Additionally, HRI is among six hemoproteins that
have a putative heme regulatory motif (HRM) where Cys at position
2 seems to be essential (19). HRI contains two of these HRMs, which
are not present in the other eIF2α kinases. The data reported here
indicate that the HRMs do not play an essential role in the heme-
responsiveness of HRI. Thus, Cys-409 and Cys-550 were mutated
individually to alanine and the entire HRM1 was deleted with no
apparent effect on either the eIF2α kinase activity or the heme
responsiveness of the HRI mutants. Furthermore, two novel eIF2α
kinases from S. pombe, highly similar to HRI, show heme
responsiveness in vitro although amino acid sequence analyses
revealed that they lacked any of this HRM.
Comparison of the deduced amino acid sequences of mammalian
HRI with the other eIF2α kinases reveals the existence in HRI of
three unique regions, very different in sequence and size, in addition
to the two kinases lobes containing the 12 conserved catalytic
subdomains characteristic of all eukaryotic Ser/Thr protein kinases.
Thus, mouse HRI comprises these five domains (Fig. 1B): the amino
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terminus, the first kinase lobe (catalytic subdomains I to IV), the
kinase insert (amino acids 236-373), the second kinase lobe (catalytic
subdomains V to XI) and the carboxyl terminus (11). The data
reported here strongly suggest that the three unique regions in HRI
(the N- and C-terminus and the kinase insert) are not involved in the
regulation of HRI activity by heme. Furthermore, we report here that
the kinase insert domain of mouse HRI is required for kinase activity
but does not play a significant role in the heme regulation of HRI.
Thus, we also observed that the HRI Q4 mutant, that contains the
kinase insert domain of mouse GCN2 instead of its own domain, is
still heme-regulated. These findings demonstrate that the binding
domain responsible for the heme regulation of HRI is located within
its two kinase lobes and, therefore, raise the possibility that some
other eIF2α kinases may also be sensitive to inhibition by heme.
To test this possibility, we attempted to determine whether
members of the other known eIF2α kinase subfamilies had the ability
to be regulated by hemin in vitro. Here, we have shown that all
recombinant mouse GCN2, Drosophila PERK and human PKR
exhibit both the autokinase and the eIF2α kinase activities in vitro
and, strikingly, these two kinase activities are inhibited by low
concentrations of hemin. Our results indicate that the heme binding
to a still unknown but well conserved region, may block the binding
of ATP and thus inhibit both the autokinase and the eIF2α kinase
activities of all known eIF2α kinases in vitro.
By comparing the amino acid sequence of mouse HRI with all
other known eIF2α kinases (up to 20 members) we have found 11
invariant positions within the kinase domain that are absent in the
majority of other Ser/Thr protein kinases. These conserved residues
are as follows: R162, D189, Y229, W233, I380, Q381, C385, F447,
G458, L462 and P569 (Fig. 1B). It is of particular interest that three
of these residues (I380, Q381 and C385), uniquely conserved among
eIF2α kinases, are located in the kinase lobe that binds ATP. Thus,
according to sequence alignment with the catalytic subunit of cAMP-
dependent protein kinase (PKA-Cα) (15), and assuming that all Ser/
Thr protein kinases fold into topologically similar three-dimensional
core structures, it was predicted that the conserved sequence
LHIQMQLCE will form a very hydrophobic β-strand (b5) in the small
kinase lobe and will connect the two lobes of the catalytic domain.
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In addition, some residues of this motif help to anchor ATP by
forming hydrogen bonds with either the adenine or the ribose ring
(15). Moreover, previous results indicate that the cysteine residue in
the HRM of six different hemoproteins is absolutely essential for
binding to heme (19). It has been suggested that such cysteine serves
the critical function of donating electrons to the iron atom of heme
(19). Therefore, it is possible that these three amino acids (I380,
Q381 and C385), the Cys-385 in particular, may be directly involved
in hemin binding, although the exact heme regulatory sites within
the eIF2α kinases remain to be determined.
Collectively, our results indicate that, although the known
regulatory mechanisms of eIF2α kinases in vivo are very different,
all known eIF2α kinases are regulated in vitro by hemin. Thus, hemin
may represent a regulatory mechanism unique to eIF2α kinases.
On the other hand, heme has been shown to function as an effector
molecule that can regulate many biological processes, including
transcription, translation, protein translocation and erythroid
differentiation. Also, heme plays key roles in oxygen sensing and
utilization in all living organisms ranging from bacteria to humans
(24). Our studies provide a new example of how heme may control
the activity of a family of translational inhibitors and how a
regulatory system may be conserved from yeast to mammals to
control protein synthesis. Thus, the eIF2α kinases may provide
a feedback mechanism to coordinate the synthesis of some
hemoproteins that are essential for the function of all aerobic cells,
according to heme concentration in eukaryotic cells. When cells grow
in a limiting supply of oxygen, the low concentration of heme
synthesized would allow the activation of the eIF2α kinases, and
a low level of protein synthesis would result. In a more aerobic
environment, heme would repress the eIF2α kinases, eliciting full
induction of protein synthesis.
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